STVN

Stevanato Group Spa

19.38

Oct 30 • 3:59 PM ET -0.86 (-4.25%)

19.00

Aftermarket • 7:29 PM ET -0.38 (-1.96%)

Healthcare Medical Instruments & Supplies Italy Mid NYSE

Peers: WST ATR BDX AVTR RGEN ICUI KRMD TMO GLW AMCR

| Held by: IBB NBSM KOMP BCSM AIMS SMLV SCAP BCGD ACSG TMED

Scroll to Statements

Index	-
Market Cap	5.29B
Enterprise Value	5.71B
Income	157.04M
Sales	1.43B
Book/sh	6.49
Cash/sh	0.33
Dividend Est.	0.04 (0.19%)
Dividend TTM	0.06 (0.33%)
Dividend Ex-Date	Jun 11, 2026
Dividend Gr. 3/5Y	0.00% -
Payout	10.76%
Employees	-
IPO	Jul 16, 2021

P/E	33.69
Forward P/E	23.85
PEG	1.44
P/S	3.70
P/B	2.99
P/C	58.85
P/FCF	-
EV/EBITDA	16.43
EV/Sales	3.99
Quick Ratio	1.08
Current Ratio	1.61
Debt/Eq	0.29
LT Debt/Eq	0.21
Option/Short	Yes / Yes

EPS (ttm)	0.58
EPS next Y	0.81
EPS next Q	0.18
EPS this Y	12.77%
EPS next Y	19.64%
EPS next 5Y	16.61%
EPS past 3/5Y	0.64% 11.33%
Sales past 3/5Y	9.00% 12.15%
EPS Y/Y TTM	7.43%
Sales Y/Y TTM	14.73%
EPS Q/Q	-20.75%
Sales Q/Q	10.63%
Earnings	Nov 03 BMO
EPS/Sales Surpr.	11.72% 2.18%

Insider Own	82.08%
Insider Trans	-0.01%
Inst Own	17.32%
Inst Trans	-0.18%
ROA	5.46%
ROE	9.20%
ROIC	7.35%
Gross Margin	28.29%
Oper. Margin	16.65%
Profit Margin	10.99%
SMA20	-0.19%
SMA50	-5.82%
SMA200	7.07%
Trades

Shs Outstand	49.83M
Shs Float	48.94M
Short Float	1.97%
Short Ratio	2.50
Short Interest	0.97M
52W High	27.00 -28.22%
52W Low	12.89 50.35%
Volatility	4.79% 3.67%
ATR (14)	0.78
RSI (14)	44.86
Beta	0.80
Rel Volume	1.44
Avg Volume	387.15K
Volume	557,678

Perf Week	-0.56%
Perf Month	-3.00%
Perf Quarter	-5.88%
Perf Half Y	9.43%
Perf YTD	-3.68%
Perf Year	-22.29%
Perf 3Y	-29.14%
Perf 5Y	-24.50%
Perf 10Y	-
Recom	1.71
Target Price	24.80
Prev Close	20.24
Price	19.38
Change %	-4.25%

Consensus

Buy

Avg. Price Target

$24.80

Implied Upside

+28.0%

Analysts13incl. previous ratings

Rating Distribution9 Buy · 4 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Oct 07, 2026	Initiated	DDeutsche Bank	Hold
Sep 09, 2026	Initiated	UUBS	Neutral
Jun 16, 2026	Initiated	TTD Cowen	Buy	$25	+29.0%
Jun 02, 2026	Resumed	WWolfe Research	Outperform	$21	+8.4%
Dec 02, 2025	Resumed	MMorgan Stanley	Equal-Weight	$24	+23.8%
Dec 13, 2024	Initiated	WWolfe Research	Outperform	$28	+44.5%
Dec 03, 2024	Resumed	MMorgan Stanley	Equal-Weight	$23	+18.7%
Apr 22, 2024	Initiated	EExane BNP Paribas	Outperform
Nov 01, 2023	Downgrade	JJefferies	Buy → Hold	$39 → $29	+49.6%
Sep 26, 2023	Initiated	SStephens	Overweight	$33	+70.3%
Sep 19, 2023	Initiated	CCJS Securities	Market Outperform
Aug 24, 2023	Downgrade	MMorgan Stanley	Overweight → Equal-Weight	$34	+75.4%
Aug 10, 2021	Initiated	WWells Fargo	Overweight	$24	+23.8%
Aug 10, 2021	Initiated	MMorgan Stanley	Overweight	$26	+34.2%
Aug 10, 2021	Initiated	KKeyBanc Capital Markets	Overweight	$27	+39.3%
Aug 10, 2021	Initiated	JJefferies	Buy	$25	+29.0%
Aug 10, 2021	Initiated	CCitigroup	Buy	$27	+39.3%
Aug 10, 2021	Initiated	BBofA Securities	Buy	$26	+34.2%

Oct-27-26 07:00AM	Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection (Business Wire)
Oct-26-26 06:21PM	Stevanato's Margin Story Faces A Third-Quarter Test As Balda Exit Mutes Reported Growth (Earnings Whispers)
Oct-20-26 04:30PM	Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026 (Business Wire)
Sep-08-26 04:05PM	Stevanato Group to Participate in Two Upcoming Investor Conferences (Business Wire)
Aug-04-26 05:02PM	Stevanato Group SpA (STVN) (Q2 2026) Earnings Call Highlights: Biologics Surge and Alina ... (GuruFocus.com)
06:44AM	Loading…
06:44AM	Stevanato: Q2 Earnings Snapshot (Associated Press)
06:30AM	Stevanato Group Delivers 8% Revenue Growth for the Second Quarter of Fiscal 2026 (Business Wire)
Jul-30-26 06:30AM	Liraglutide Combination Products Incorporating Stevanato Group's Alina Pen Injector Received Marketing Authorizations in Multiple European Countries (Business Wire)
Jul-21-26 06:30AM	Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026 (Business Wire)
Jun-08-26 06:30AM	Stevanato Group Introduces Deora, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management (Business Wire)
Jun-03-26 05:45PM	Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders' Meeting (Business Wire)
May-07-26 06:41AM	Stevanato: Q1 Earnings Snapshot (Associated Press) -5.11%
06:30AM	Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026 (Business Wire)
May-04-26 05:45PM	Stevanato Group to Participate in Three Upcoming Investor Conferences (Business Wire)
Apr-23-26 04:05PM	Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026 (Business Wire)
04:45PM	Loading…
Mar-12-26 04:45PM	Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum (Business Wire)
Mar-04-26 04:01PM	Stevanato Group SpA (STVN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com) +18.81% -9.09%
01:47PM	Stevanato Group Q4 Earnings Call Highlights (MarketBeat)
07:45AM	Stevanato Group (STVN) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
06:48AM	Stevanato: Q4 Earnings Snapshot (Associated Press Finance)
06:30AM	Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins (Business Wire)
Feb-26-26 09:55AM	Indivior Pharmaceuticals Inc. (INDV) Tops Q4 Earnings and Revenue Estimates (Zacks)
Feb-19-26 07:35AM	Here's What Hurt Stevanato Group SpA (STVN) in Q4 (Insider Monkey)
06:30AM	Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026 (Business Wire)
Jan-26-26 11:40AM	STVN or MDGL: Which Is the Better Value Stock Right Now? (Zacks)
Jan-23-26 04:34PM	Stocks Finish Mostly Higher Despite a Plunge in Intel (Barchart) -9.86%
Jan-20-26 09:05AM	Stevanato (STVN) Declined Due to Anticipation of Soft Quarter Ahead (Insider Monkey)
Jan-16-26 05:05AM	Datwyler, LTS Device Technologies, and Stevanato Group Collaborate to Expand Self-Delivery Options for Large-Volume Drugs (PR Newswire) -5.95%
Dec-24-25 08:34AM	Are Options Traders Betting on a Big Move in Stevanato Group Stock? (Zacks)
Dec-19-25 11:40AM	SDZNY vs. STVN: Which Stock Is the Better Value Option? (Zacks)
11:40AM	Loading…
Dec-03-25 11:40AM	SDZNY vs. STVN: Which Stock Should Value Investors Buy Now? (Zacks) +5.70%
Nov-06-25 07:45AM	Stevanato Group (STVN) Q3 Earnings and Revenues Surpass Estimates (Zacks)
06:38AM	Stevanato: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	Stevanato Group Reports Revenue of 303.2 Million for the Third Quarter of 2025 (Business Wire)
Oct-31-25 12:09PM	SDZNY vs. STVN: Which Stock Is the Better Value Option? (Zacks)
07:30AM	Stevanato Group to Participate in Upcoming Investor Conferences (Business Wire)
Oct-22-25 06:30AM	Stevanato Group to Report Third Quarter 2025 Financial Results on November 6, 2025 (Business Wire)
Oct-21-25 06:30AM	Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings (Business Wire)
Oct-10-25 11:40AM	GRFS vs. STVN: Which Stock Should Value Investors Buy Now? (Zacks)
Oct-07-25 06:04AM	NewAmsterdam Pharma Company N.V. (NAMS) Soars 5.9%: Is Further Upside Left in the Stock? (Zacks)
Sep-15-25 11:40AM	USNA vs. STVN: Which Stock Is the Better Value Option? (Zacks)
Sep-12-25 08:16AM	Stevanato Group SpA (STVN) Share Gained 20% as Results Exceeded Expectations (Insider Monkey)
Sep-11-25 12:00PM	Stevanato (STVN) Upgraded to Buy: Here's What You Should Know (Zacks)
Sep-02-25 05:59PM	Stevanato Group to Participate in Upcoming Investor Conferences (Business Wire)
Aug-28-25 11:40AM	USNA or STVN: Which Is the Better Value Stock Right Now? (Zacks)
Aug-25-25 08:30AM	Here's Why Artisan Small Cap Fund Increased its Holdings in Stevanato Group S.p.A. (STVN) (Insider Monkey)
Aug-12-25 11:40AM	USNA vs. STVN: Which Stock Is the Better Value Option? (Zacks)
Aug-05-25 07:40AM	Stevanato Group (STVN) Q2 Earnings and Revenues Beat Estimates (Zacks) -9.73%
06:38AM	Stevanato: Q2 Earnings Snapshot (Associated Press Finance)
06:30AM	Stevanato Group Reports Revenue of 280.0 Million for the Second Quarter of 2025 (Business Wire)
Jul-29-25 10:00AM	Stevanato Group (STVN) Earnings Expected to Grow: Should You Buy? (Zacks)
Jul-25-25 11:40AM	MKKGY or STVN: Which Is the Better Value Stock Right Now? (Zacks) -5.15%
10:06AM	Stevanato (STVN) Soars 10.0%: Is Further Upside Left in the Stock? (Zacks)
Jul-23-25 01:18PM	Will Escalating Medical Costs Dampen Centene's Q2 Earnings? (Zacks)
06:30AM	Stevanato Group Secures 200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S. (Business Wire)
Jul-22-25 04:30PM	Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025 (Business Wire)
Jul-09-25 11:40AM	CPRX or STVN: Which Is the Better Value Stock Right Now? (Zacks)
Jun-18-25 11:40AM	KMDA vs. ACAD: Which Stock Is the Better Value Option? (Zacks)
11:40AM	FMS or RXST: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	GBOOY vs. BAM: Which Stock Should Value Investors Buy Now? (Zacks)
11:40AM	FLEX vs. GRMN: Which Stock Is the Better Value Option? (Zacks)
11:40AM	GLDD vs. DY: Which Stock Is the Better Value Option? (Zacks)
11:40AM	DNBBY or CMWAY: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	CCU or SAM: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	TTEC or MLNK: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	STRT or RACE: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	STNE vs. FFIV: Which Stock Is the Better Value Option? (Zacks)
11:40AM	GO or KMB: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	CRRFY or WMT: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	ASAIY vs. K: Which Stock Is the Better Value Option? (Zacks)
11:40AM	USNA vs. STVN: Which Stock Is the Better Value Option? (Zacks)
Jun-02-25 11:40AM	GRFS vs. STVN: Which Stock Is the Better Value Option? (Zacks)
May-30-25 01:07AM	Stevanato Group S.p.A. (STVN): A Bull Case Theory (Insider Monkey)
May-09-25 04:03PM	Stevanato Group to Participate in Upcoming Investor Conferences (Business Wire) +6.76%
03:20AM	Stevanato Group SpA (STVN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
May-08-25 07:50AM	Stevanato Group (STVN) Q1 Earnings and Revenues Top Estimates (Zacks)
06:46AM	Stevanato: Q1 Earnings Snapshot (Associated Press Finance)
06:37AM	Stevanato Group Reports Revenue of 256.6 Million for the First Quarter of 2025 (Business Wire)
May-07-25 09:41AM	Stevanato Group SpA (STVN) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
May-06-25 11:40AM	SDZNY vs. STVN: Which Stock Should Value Investors Buy Now? (Zacks)
08:55AM	Heron Therapeutics (HRTX) Q1 Earnings and Revenues Top Estimates (Zacks)
Apr-24-25 05:15PM	Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025 (Business Wire)
Mar-11-25 04:30PM	Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum (Business Wire) -6.46%
Mar-07-25 02:09AM	Stevanato Group SpA (STVN) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com)
01:52AM	Q4 2024 Stevanato Group SpA Earnings Call (Thomson Reuters StreetEvents)
Mar-06-25 07:45AM	Stevanato Group (STVN) Meets Q4 Earnings Estimates (Zacks) +8.60%
06:48AM	Stevanato: Q4 Earnings Snapshot (Associated Press Finance)
06:31AM	Stevanato Group Reports Record Revenue of 1,104 Million for Fiscal Year 2024 (Business Wire)
Mar-05-25 07:05AM	Earnings To Watch: Stevanato Group SpA (STVN) Reports Q4 2024 Result (GuruFocus.com)
Feb-24-25 04:02PM	Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025 (Business Wire)
Feb-23-25 01:35PM	Stevanato Group S.p.A. (STVN): the Most Oversold Pharma Stock to Buy According to Analysts (Insider Monkey)
Feb-13-25 12:16AM	Is Stevanato Group S.p.A. (STVN) the Best Italian Stock to Buy in 2025? (Insider Monkey) -5.08%
Jan-07-25 04:30PM	Stevanato Group to Present at Upcoming Investor Conference (Business Wire)
Dec-14-24 06:45AM	Wolfe starts Stevanato with Outperform on return to growth (TipRanks)
Dec-04-24 07:55AM	Stevanato Group assumed with an Equal Weight at Morgan Stanley (TipRanks)
Nov-11-24 06:32AM	Stevanato Group to Present at Upcoming Investor Conferences (Business Wire)
Nov-06-24 02:13AM	Stevanato Group SpA (STVN) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com)
Nov-05-24 07:45AM	Stevanato Group (STVN) Q3 Earnings Match Estimates (Zacks) +16.10%
06:43AM	Stevanato: Q3 Earnings Snapshot (Associated Press Finance)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stocchi Mauro	See Remarks	Sep 28 '26	Sale	21.50	13,649	293,454	400,000	Sep 30 05:20 PM
Mauro Stocchi	Officer	Sep 14 '26	Proposed Sale	20.24	13,649	276,255		Sep 14 09:57 AM
Santel Luciano	Director	Aug 07 '26	Sale	20.09	2,023	40,642	4,739	Aug 10 04:15 PM
Dal Lago Marco	Chief Financial Officer	Aug 07 '26	Sale	20.09	4,209	84,559	81,144	Aug 10 04:15 PM
Magistretti Elisabetta	Director	Aug 07 '26	Sale	20.09	2,045	41,084	2,930	Aug 10 04:15 PM
Dal Lago Marco	Chief Financial Officer	Aug 07 '26	Proposed Sale	20.09	4,209	84,555		Aug 07 11:56 AM
Balachandran Madhavan	Director	Jun 15 '26	Sale	17.09	1,493	25,515	69,458	Jun 26 06:18 AM
Dal Lago Marco	Chief Financial Officer	Jun 12 '26	Option Exercise	0.00	7,997	0	85,353	Jun 26 06:16 AM
MOREL DONALD E JR	Director	Jun 15 '26	Sale	17.09	1,493	25,515	37,424	Jun 26 06:12 AM
Stocchi Mauro	See Remarks	Jun 09 '26	Option Exercise	0.00	6,586	0	413,629	Jun 26 06:07 AM
Flynn Karen	Director	Jun 15 '26	Sale	17.09	1,493	25,515	5,757	Jun 26 06:05 AM
FEDERICI WILLIAM J	Director	Jun 15 '26	Sale	17.09	1,493	25,515	26,991	Jun 26 06:04 AM

Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.

CEO & Executive ChairmanMr. Franco Stevanato

Chief Financial OfficerMr. Marco Dal Lago

Chief Communications & Investor Relations OfficerMs. Lisa Miles

Chief Human Resources OfficerMs. Carla Costa

Chief Business OfficerMr. Mauro Stocchi

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

STVN

Stevanato Group Spa

Upgrade your Finviz experience